Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 12,503.0 | 10,675.0 | 8,471.0 | 8,236.0 | 8,304.0 | 8,541.0 | 8,551.0 | 8,419.0 |
| Revenue growth | 17.1% | 26.0% | 2.9% | -0.8% | -2.8% | -0.1% | 1.6% | -4.8% |
| Cost of goods sold | 4,841.0 | 4,688.0 | 4,058.0 | 3,678.0 | 4,321.0 | 4,464.0 | 4,544.0 | 4,488.0 |
| Gross profit | 7,662.0 | 5,987.0 | 4,413.0 | 4,558.0 | 3,983.0 | 4,077.0 | 4,007.0 | 3,931.0 |
| Gross margin | 61.3% | 56.1% | 52.1% | 55.3% | 48.0% | 47.7% | 46.9% | 46.7% |
| Selling, general and administrative | 1,931.0 | 2,098.0 | 1,871.0 | 1,389.0 | 1,470.0 | 1,606.0 | 1,480.0 | 1,517.0 |
| EBITA | 5,731.0 | 3,790.0 | 2,542.0 | 3,169.0 | 2,513.0 | 2,471.0 | 2,489.0 | 2,358.0 |
| EBITA margin | 45.8% | 35.5% | 30.0% | 38.5% | 30.3% | 28.9% | 29.1% | 28.0% |
| Amortization of intangibles | 23.0 | 18.0 | 11.0 | 5.0 | 21.0 | 24.0 | 25.0 | 28.0 |
| EBIT | 5,708.0 | 3,772.0 | 2,531.0 | 3,164.0 | 2,492.0 | 2,447.0 | 2,464.0 | 2,330.0 |
| EBIT margin | 45.7% | 35.3% | 29.9% | 38.4% | 30.0% | 28.7% | 28.8% | 27.7% |
| Pre-tax income | 9,691.0 | 6,384.0 | 2,262.0 | 2,741.0 | 1,953.0 | 2,186.0 | 2,205.0 | 1,522.0 |
| Income taxes | 3,618.0 | 3,131.0 | 817.0 | 1,023.0 | 681.0 | 780.0 | 868.0 | 567.0 |
| Tax rate | 37.3% | 49.0% | 36.1% | 37.3% | 34.9% | 35.7% | 39.4% | 37.3% |
| Earnings from continuing ops | 6,073.0 | 3,253.0 | 1,445.0 | 1,718.0 | 1,272.0 | 1,406.0 | 1,337.0 | 955.0 |
| Earnings from discontinued ops | | | 25.0 | | | | -216.0 | |
| Net income | 6,073.0 | 3,253.0 | 1,470.0 | 1,718.0 | 1,272.0 | 1,406.0 | 1,121.0 | 955.0 |
| Net margin | 48.6% | 30.5% | 17.4% | 20.9% | 15.3% | 16.5% | 13.1% | 11.3% |
| |
| Diluted EPS | $4.25 | $2.57 | $1.35 | $1.57 | $2.24 | $2.40 | $2.29 | $1.64 |
| Shares outstanding (diluted) | 1,429.9 | 1,267.7 | 1,069.9 | 1,093.9 | 567.9 | 585.4 | 584.9 | 583.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|